
Chr. Hansen Holding A/S
CRTSF
Updated: 24/09/2026, 17:41:56
No historical data available
Chr. Hansen Holding A/S is a global bioscience firm dedicated to developing natural ingredient solutions. These innovative offerings serve the food, nutritional, pharmaceutical, and agricultural sectors across a wide geographical spread, encompassing Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's operations are divided into two main segments: Food Cultures & Enzymes, and Health & Nutrition. Within the Food Cultures & Enzymes division, Chr. Hansen manufactures and supplies a diverse range of cultures, enzymes, and probiotic products. These essential components are pivotal in shaping the taste, aroma, texture, preservation, nutritional profile, and health advantages of various consumer food items, particularly within the dairy industry. The Health & Nutrition segment, on the other hand, provides specialized products for markets such as dietary supplements, over-the-counter pharmaceuticals, infant nutrition, animal feed, and crop protection. Furthermore, Chr. Hansen has established a strategic partnership with UPL Ltd. to jointly advance and commercialize microbial biological solutions aimed at fostering sustainable agriculture. This enterprise, founded in 1843, is based in Hørsholm, Denmark.
No summaries found.
- Share price
- $79.30
- Market cap
- $10.44B
- Exchange
- OTC
- Currency
- USD
- CEO
- Mauricio Graber
- Employees
- 3,834
- IPO date
- 15/05/2012
- Beta
- 0.325
- Last dividend
- $0.00
- Day range
- $79.30 – $79.54
- 52-week range
- $61.43 – $79.54
- 1-day performance
- 5.73%
- 1-year performance
- 29.09%
- Current drawdown (1Y)
- -0.30%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- DK0060227585
- Created
- 07/12/2025, 03:27:44
- Last update
- 24/09/2026, 17:41:56
Track Chr. Hansen Holding A/S with an AI analyst
See which prediction-market events move CRTSF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.